Cancer Care Ontario | Cancer Care Ontario

361 Results

Guidelines and Advice

Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery

Status: Current
ID: GL 17-12
Version: N/A

Sep 2019

Guidelines and Advice

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Status: Current
ID: 7-A-2018-3

Feb 2021

Guidelines and Advice

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Status: Current
ID: 7-A-2022-1-17v3
Version: 3

Oct 2023

Guidelines and Advice

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Status: In-Review
ID: RR SCT-9
Version: N/A

Jun 2020

Guidelines and Advice

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Status: In-Review
ID: GL END 3-24

Aug 2022

Guidelines and Advice

Optimization of Surgical and Pathological Quality Performance in Radical Surgery for Colon and Rectal Cancer: Margins and Lymph Nodes

Status: Current
ID: 17-4
Version: 2

Nov 2016

Guidelines and Advice

Bone Health and Bone-Targeted Therapies for Prostate Cancer

Status: Current
ID: 3-14
Version: 3

Updated

Jun 2025

Guidelines and Advice

Self-Management Education for Patients with Cancer: Evidence Summary

Status: Archived
ID: 20-3

Jan 2016

Guidelines and Advice

Consensus Pathology Recommendations for Complex Malignant Hematology – December 2016

Status: Current
ID: GL-C50-28

Dec 2016

Guidelines and Advice

Endometrial Cancer Molecular Testing Recommendations Report

Status: Current
Version: 1

Nov 2024

Guidelines and Advice

Preoperative Breast Magnetic Resonance Imaging

Status: Current
ID: GL 1-25
Version: N/A

Mar 2023

Guidelines and Advice

Comparison of PET/CT and PET/MR Imaging in Oncology

Status: Current
ID: ES PET 16
Version: 2

Apr 2024

Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Optimization of Surgical and Pathological Quality Performance in Radical Surgery for Colon and Rectal Cancer: Margins and Lymph Nodes

Bone Health and Bone-Targeted Therapies for Prostate Cancer

Self-Management Education for Patients with Cancer: Evidence Summary

Consensus Pathology Recommendations for Complex Malignant Hematology – December 2016

Endometrial Cancer Molecular Testing Recommendations Report

Preoperative Breast Magnetic Resonance Imaging

Comparison of PET/CT and PET/MR Imaging in Oncology

Pages